Under current FDA draft guidelines, a single acute dosing session can require up to eight hours of continuous monitoring by at least two qualified clinicians typically a licensed lead therapist and an assistant monitor. Add mandatory training programs, specialized treatment environments, and post-session follow-up, and you have a delivery model that works in a well-funded research setting and becomes genuinely difficult everywhere else.
